List of Tables
Table 1. Global Malignant Mesothelioma Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Malignant Mesothelioma Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Malignant Mesothelioma Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Malignant Mesothelioma Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Malignant Mesothelioma Market Share by Region (2018-2023)
Table 8. Global Malignant Mesothelioma Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Malignant Mesothelioma Market Share by Region (2024-2029)
Table 10. Malignant Mesothelioma Market Trends
Table 11. Malignant Mesothelioma Market Drivers
Table 12. Malignant Mesothelioma Market Challenges
Table 13. Malignant Mesothelioma Market Restraints
Table 14. Global Malignant Mesothelioma Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Malignant Mesothelioma Revenue Share by Players (2018-2023)
Table 16. Global Top Malignant Mesothelioma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Mesothelioma as of 2022)
Table 17. Global Malignant Mesothelioma Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Malignant Mesothelioma Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Malignant Mesothelioma, Headquarters and Area Served
Table 20. Global Key Players of Malignant Mesothelioma, Product and Application
Table 21. Global Key Players of Malignant Mesothelioma, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Malignant Mesothelioma Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Malignant Mesothelioma Revenue Market Share by Type (2018-2023)
Table 25. Global Malignant Mesothelioma Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Malignant Mesothelioma Revenue Market Share by Type (2024-2029)
Table 27. Global Malignant Mesothelioma Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Malignant Mesothelioma Revenue Share by Application (2018-2023)
Table 29. Global Malignant Mesothelioma Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Malignant Mesothelioma Revenue Share by Application (2024-2029)
Table 31. North America Malignant Mesothelioma Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Malignant Mesothelioma Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Malignant Mesothelioma Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Malignant Mesothelioma Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Malignant Mesothelioma Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Malignant Mesothelioma Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Malignant Mesothelioma Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Malignant Mesothelioma Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Malignant Mesothelioma Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Malignant Mesothelioma Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Malignant Mesothelioma Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Malignant Mesothelioma Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Malignant Mesothelioma Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Malignant Mesothelioma Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Malignant Mesothelioma Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Malignant Mesothelioma Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Malignant Mesothelioma Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Malignant Mesothelioma Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Malignant Mesothelioma Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Malignant Mesothelioma Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Malignant Mesothelioma Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Malignant Mesothelioma Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Malignant Mesothelioma Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Malignant Mesothelioma Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Malignant Mesothelioma Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Malignant Mesothelioma Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size by Country (2024-2029) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Malignant Mesothelioma Product
Table 66. AstraZeneca Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 67. AstraZeneca Recent Developments
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Malignant Mesothelioma Product
Table 71. Bristol-Myers Squibb Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Developments
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Malignant Mesothelioma Product
Table 76. Roche Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 77. Roche Recent Developments
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Malignant Mesothelioma Product
Table 81. Merck Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 82. Merck Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Malignant Mesothelioma Product
Table 86. Novartis Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Malignant Mesothelioma Product
Table 91. Pfizer Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 92. Pfizer Recent Developments
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Malignant Mesothelioma Product
Table 96. Sanofi Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 97. Sanofi Recent Developments
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Malignant Mesothelioma Product
Table 101. Eli Lilly Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 102. Eli Lilly Recent Developments
Table 103. Teva Pharmaceuticals Company Details
Table 104. Teva Pharmaceuticals Business Overview
Table 105. Teva Pharmaceuticals Malignant Mesothelioma Product
Table 106. Teva Pharmaceuticals Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 107. Teva Pharmaceuticals Recent Developments
Table 108. Boehringer Ingelheim GmbH Company Details
Table 109. Boehringer Ingelheim GmbH Business Overview
Table 110. Boehringer Ingelheim GmbH Malignant Mesothelioma Product
Table 111. Boehringer Ingelheim GmbH Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 112. Boehringer Ingelheim GmbH Recent Developments
Table 113. Mylan Company Details
Table 114. Mylan Business Overview
Table 115. Mylan Malignant Mesothelioma Product
Table 116. Mylan Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 117. Mylan Recent Developments
Table 118. Fresenius Kabi Company Details
Table 119. Fresenius Kabi Business Overview
Table 120. Fresenius Kabi Malignant Mesothelioma Product
Table 121. Fresenius Kabi Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 122. Fresenius Kabi Recent Developments
Table 123. Sun Pharmaceuticals Company Details
Table 124. Sun Pharmaceuticals Business Overview
Table 125. Sun Pharmaceuticals Malignant Mesothelioma Product
Table 126. Sun Pharmaceuticals Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 127. Sun Pharmaceuticals Recent Developments
Table 128. Corden Pharma Company Details
Table 129. Corden Pharma Business Overview
Table 130. Corden Pharma Malignant Mesothelioma Product
Table 131. Corden Pharma Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 132. Corden Pharma Recent Developments
Table 133. Concordia International Company Details
Table 134. Concordia International Business Overview
Table 135. Concordia International Malignant Mesothelioma Product
Table 136. Concordia International Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 137. Concordia International Recent Developments
Table 138. Kyowa Hakko Kirin Company Details
Table 139. Kyowa Hakko Kirin Business Overview
Table 140. Kyowa Hakko Kirin Malignant Mesothelioma Product
Table 141. Kyowa Hakko Kirin Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 142. Kyowa Hakko Kirin Recent Developments
Table 143. Polaris Pharmaceuticals Company Details
Table 144. Polaris Pharmaceuticals Business Overview
Table 145. Polaris Pharmaceuticals Malignant Mesothelioma Product
Table 146. Polaris Pharmaceuticals Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 147. Polaris Pharmaceuticals Recent Developments
Table 148. MolMed Company Details
Table 149. MolMed Business Overview
Table 150. MolMed Malignant Mesothelioma Product
Table 151. MolMed Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 152. MolMed Recent Developments
Table 153. Ono Pharmaceutical Company Details
Table 154. Ono Pharmaceutical Business Overview
Table 155. Ono Pharmaceutical Malignant Mesothelioma Product
Table 156. Ono Pharmaceutical Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 157. Ono Pharmaceutical Recent Developments
Table 158. Nichi-Iko Pharmaceutical Company Details
Table 159. Nichi-Iko Pharmaceutical Business Overview
Table 160. Nichi-Iko Pharmaceutical Malignant Mesothelioma Product
Table 161. Nichi-Iko Pharmaceutical Revenue in Malignant Mesothelioma Business (2018-2023) & (US$ Million)
Table 162. Nichi-Iko Pharmaceutical Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Malignant Mesothelioma Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Malignant Mesothelioma Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Parenteral Features
Figure 5. Global Malignant Mesothelioma Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Malignant Mesothelioma Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Oncology Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Malignant Mesothelioma Report Years Considered
Figure 12. Global Malignant Mesothelioma Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Malignant Mesothelioma Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Malignant Mesothelioma Market Share by Region: 2022 VS 2029
Figure 15. Global Malignant Mesothelioma Market Share by Players in 2022
Figure 16. Global Top Malignant Mesothelioma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Mesothelioma as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Malignant Mesothelioma Revenue in 2022
Figure 18. North America Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Malignant Mesothelioma Market Share by Type (2018-2029)
Figure 20. North America Malignant Mesothelioma Market Share by Application (2018-2029)
Figure 21. North America Malignant Mesothelioma Market Share by Country (2018-2029)
Figure 22. United States Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Malignant Mesothelioma Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Malignant Mesothelioma Market Share by Type (2018-2029)
Figure 26. Europe Malignant Mesothelioma Market Share by Application (2018-2029)
Figure 27. Europe Malignant Mesothelioma Market Share by Country (2018-2029)
Figure 28. Germany Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Malignant Mesothelioma Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Malignant Mesothelioma Market Share by Type (2018-2029)
Figure 36. China Malignant Mesothelioma Market Share by Application (2018-2029)
Figure 37. Asia Malignant Mesothelioma Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Malignant Mesothelioma Market Share by Type (2018-2029)
Figure 39. Asia Malignant Mesothelioma Market Share by Application (2018-2029)
Figure 40. Asia Malignant Mesothelioma Market Share by Region (2018-2029)
Figure 41. Japan Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Malignant Mesothelioma Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Malignant Mesothelioma Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Malignant Mesothelioma Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Malignant Mesothelioma Market Share by Country (2018-2029)
Figure 51. Brazil Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Malignant Mesothelioma Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 60. Merck Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 62. Pfizer Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 63. Sanofi Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 64. Eli Lilly Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 66. Boehringer Ingelheim GmbH Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 67. Mylan Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 68. Fresenius Kabi Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 69. Sun Pharmaceuticals Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 70. Corden Pharma Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 71. Concordia International Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 72. Kyowa Hakko Kirin Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 73. Polaris Pharmaceuticals Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 74. MolMed Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 75. Ono Pharmaceutical Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 76. Nichi-Iko Pharmaceutical Revenue Growth Rate in Malignant Mesothelioma Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed